Catalyst Wire Dossier Catalyst Wire Dossier

AMG 820

unknown · AmMax Bio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG 820, covering 2020-06-01 to 2020-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer [Phase 1, Phase 2]

See pricing